Oncotelic Therapeutics Inc – Filings and Transcripts – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Financials Filter

ended 09/30/24 Q3

Late quarterly filing notification for Q3 2024

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

Prospectuses and Registrations Filter

Prospectus supplement

Updated info for already-effective prospectus

Updated info for already-effective prospectus

Exempt offering of securities

Prospectus supplement

Ownership Filter

News Filter

Other Events, Financial Statements or Exhibits

To Sell Its Necroptosis Cancer Therapy Assets to Mosaic ImmunoEngineering, Inc

Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements or Exhibits

Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements or Exhibits

Sapu BioScience and Cromos Pharma Initiating P201 – A Registrational Trial for OT-101 in Pancreatic Cancer

Proxies Filter

Definitive proxy

Preliminary revised proxy

Preliminary revised proxy

Preliminary proxy

Preliminary revised proxy

Other Filter

Notice of effectiveness

Notice of effectiveness

Notice of effectiveness

Notice of effectiveness

Notice of effectiveness